OpenAI launches Rosalind Biodefense program to share life sciences model with governments

OpenAI launched the Rosalind Biodefense program, granting selected developers and government partners access to GPT-Rosalind, its life sciences reasoning model that handles molecules, proteins, genes, and disease biology. Early partners include Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, and vaccine initiative CEPI. The effort targets pandemic preparedness, early warning systems, diagnostics, and vaccine development, with OpenAI covering access costs for vetted developers. The program responds to repeated warnings from OpenAI and Anthropic about AI-enabled bioweapon risks by routing the model toward defensive research.

View full digest for May 30, 2026